You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

1 Reports indicate that a shortage of GLP-1 drugs began in late 2022 and has continued well ... complications as well as both ...

That means it could be dosed without considering meal timings, which is a consideration with some drugs in the oral GLP-1 class. For example, Novo Nordisk's oral formulation of semaglutide for dia ...

As Ozempic and other GLP-1 drugs explode in popularity ... Social media influencers, often unregulated, showcase examples of rapid weight loss, sometimes using images of individuals who wouldn ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

For example, during the event, AstraZeneca shared promising early data for its oral GLP-1 candidate, AZD5004, and told Fierce ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.